Board of Regents and Executive Committee Decisions

February 13, 2018

Following are key actions taken by the Board of Regents at the Oct. 26 meeting and by the Executive Committee during its Dec. 18 teleconference. 

  • Approved increasing the size of the committees under the Advocacy Council to 15 members and amending the Governance Manual accordingly.
  • Approved revisions to the speaker and moderator reimbursement policy.
  • Approved revisions to the Conflict of Interest Leadership Issues Related to Service in ACAAI policy.
  • Designated Anaheim (Nov. 9-13), with Seattle as an alternate, as the site for the 2023 Annual Meeting contingent upon a successful site visit and contract negotiations.
  • Requested the Bylaws Committee develop an amendment to the Bylaws to enable AOA Board Certified allergists to qualify for Fellowship.
  • Approved the recommended 2017-2019 committee and council appointments.
  • Authorized the President to establish a College work group to articulate the financial issues affecting academic allergists and identify the stakeholders who should be engaged to answer those questions.
  • Authorized the President to appoint a task force to develop the topics and criteria for future yardsticks.
  • Ratified the decision for the College to support the ACP position paper titled "Addressing Social Determinants to Improve Patient Care and Promote Health Equity: An American College of Physicians Position Paper."
  • Ratified the endorsement of the EAACI/GALEN/EDF/WAO Urticaria Guidelines as recommended by the Executive Committee.
  • Ratified the decision for the College to endorse “The International WAO/EAACI Guideline for the Management of Hereditary Angioedema – the 2017 Revision and Update” at the recommendation of the Anaphylaxis Committee.
  • Approved the proposed 2018 budget.
  • Accepted the recommendation of the Budget Committee to allocate $5,000 per region to support speaker travel to international meetings and authorize the President and President Elect to select the meetings for which College support is provided.
  • Approved tentative participation in a joint program with the American Academy of Pediatrics and the National Peanut Board to educate the public about early peanut introduction pending additional information, and authorize the President to appoint a College member as our representative.
  • Appointed Dr. Stanley Fineman as a Trustee-at-Large on the Foundation Board for a 4-year term beginning Oct. 30, 2017.
  • Ratifed the appointment of Drs. Chipps, Mahr and Tilles as ACAAI Delegates to the WAO House of Delegates for 2018-2019.
  • Approved not funding speaker travel to international meetings that take place in countries with travel advisories issued by the U.S. State Department and amend the International Meeting Funding Policy accordingly.
  • Approved requests for Retired and Emeritus status as presented.
  • Approved the JTFPP’s plan to continue to develop (in addition to guidelines using the GRADE format) the more traditional updated practice parameters on the topics of Drug Allergy and Anaphylaxis.
  • Approved Drs. Bradley Chipps and John Oppenheimer for renewed 4-year terms as AllergyWatch Assistant Editors beginning January 2018.
  • Approved appointing the following members as Annals Associate Editors for a one-year term beginning January 2018: Drs. Mariana Castells, Mitch Grayson, Matt Greenhawt, Jay Lieberman, Jonathan Spergel, and John Oppenheimer.
  • Approved appointing Drs. Anne Ellis and Anna Nowak-Wegrzyn as Annals Deputy Editors for a one-year term beginning January 2018.
  • Approved reappointing the following Annals Editorial Board members for a 2-year term beginning January 2018: Lisa M. Bartnikas, MD;  Ruchi S. Gupta, MD, MPH; Jonathan A. Bernstein, MD; Terry O. Harville, PhD; Michael S. Blaiss, MD; Richard W. Honsinger, MD; Michael Blumberg, MD; Corinne Allison Keet, MD; Christopher W. Calabria, MD; Guha Krishnaswamy, MD; Bradley E. Chipps, MD; Désirée E. Larenas-Linnemann, MD; Giorgio Ciprandi, MD; Dennis K. Ledford, MD; Donald W. Cockcroft, MD; D. Betty Lew, MD; Christopher Albert Coop, MD; Andrew MacGinnitie, MD, PhD; Linda S. Cox, MD; Eric M. Macy, MD; Mauli Desai, MD; John B. Meiser, MD; Richard D. deShazo, MD; Talal M. Nsouli, MD; Chitra Dinakar, MD; Gary S. Rachelefsky, MD; Sten Dreborg, MD; Ahmad R. Sedaghat, MD; Elizabeth A. Erwin; Joram S. Seggev, MD; Robert E. Esch, PhD Roland Solensky, MD; Enrique Fernandez-Caldas, MD; Ricardo Tan, MD; Stanley M. Fineman, MD; Ronald S. Walls, MD, PhD; Theodore M. Freeman, MD Richard L. Wasserman, MD, PhD; Maureen George, PhD; Miles M. Weinberger, MD; David B.K. Golden, MD; Kevin M. White, MD; Paul A. Greenberger, MD.
  • Approved appointing the following members to the Annals Editorial Board for a 2-year term beginning January 2018: John A. Bird, MD; John R. Cohn, MD; Alan P. Knutsen, MD; Bruce J. Lanser, MD; Iris Otani, MD; David R. Stukus, MD; Jonathan S. Tam, MD; Richard Weber, MD.
  • Authorized the President to appoint a task force to develop a competitive $5,000 grant program, to be awarded to a training program, to validate the value of allergist care for the treatment of asthma.
  • Approved the 2018-2020 Strategic Plan.
  • Approved the Advocacy Council of ACAAI join the coalition - Biologics Prescribers Collaborative – which ensures physicians who prescribe complex biologic treatments are included in the formation of policy that shapes the use of biosimilars.
  • Approved free Alliance membership for all spouses/significant others and eliminate Alliance membership dues beginning in 2018.
  • Approved the nomination of Dr. Mark Corbett (with Dr. Bill Dolen as alternate) to the ABMS Vision Commission by the 1/1/18 nomination deadline date and request the EMD to ask the AAAAI whether they are interested in submitting a joint nomination.
  • Requested the President work with the AAAAI leadership to determine an appropriate individual to jointly nominate for consideration to serve on the CDC Advisory Committee on Immunization Practices.
  • Approved charging ACAAI Allied Health Members an early registration rate of $275, and non-ACAAI Allied Health Members an early registration rate of $350 to attend the 2018 Annual Meeting which would include access to the general annual meeting sessions, the Allied Health Professionals Course and Advance Practice Course at no additional fee.
  • Approved the 2018 Spouse/Guest Hospitality Suite to be open Friday, Saturday and Sunday mornings during the 2018 Annual Meeting.
  • Ratified the decision to have the Asthma Committee to review the American College of Chest Physicians’ Treating Cough due to Non-CF and CF Bronchiectasis with Non-Pharmacological Airway Clearance: CHEST Expert Panel Report and authorized the President to provide College endorsement of the document if recommended by the Officers.
  • Approved the participation of Dr. Peng in the SPARK workgroup.
  • Reached a consensus to offer a SPARK program at the 2018 Annual Meeting funded up to $25,000 by the ACAAI Foundation.
  • Approved the administration of a joint ACAAI-BSACI survey to collect information on skin testing practices among College members.
  • Approved the establishment of a strategic partnership between the College and the National Food Allergy Death Registry.
  • Approved sending a SLIT follow-up survey to members, contingent on the Executive Medical Director’s review of the survey.